Hypertrophic Cardiomyopathy (HCM) Clinical Trials

10 recruiting

Hypertrophic Cardiomyopathy (HCM) Trials at a Glance

10 actively recruiting trials for hypertrophic cardiomyopathy (hcm) are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Beijing, Birmingham, and Bologna. Lead sponsors running hypertrophic cardiomyopathy (hcm) studies include Christopher Kramer, Deutsches Herzzentrum Muenchen, and Chinese Academy of Medical Sciences, Fuwai Hospital.

Browse hypertrophic cardiomyopathy (hcm) trials by phase

Treatments under study

About Hypertrophic Cardiomyopathy (HCM) Clinical Trials

Looking for clinical trials for Hypertrophic Cardiomyopathy (HCM)? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hypertrophic Cardiomyopathy (HCM) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hypertrophic Cardiomyopathy (HCM) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Multicentre Hypertrophic Cardiomyopathy Registry

Hypertrophic Cardiomyopathy (HCM)
University of Manchester2,500 enrolled1 locationNCT07381894
Recruiting

HCMR Re-Imaging Study

Hypertrophic Cardiomyopathy (HCM)
Christopher Kramer314 enrolled8 locationsNCT07054073
Recruiting
Phase 1Phase 2

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

TumorCardiovascular DiseasesPulmonary Fibrosis+3 more
Peking Union Medical College Hospital30 enrolled1 locationNCT07464132
Recruiting

Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)

Heart FailureHypertrophic Cardiomyopathy (HCM)RASopathy
Deutsches Herzzentrum Muenchen100 enrolled1 locationNCT07344480
Recruiting

Multimodal Analysis of Endomyocardial Biopsies

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Heart Transplantation+4 more
University Hospital, Essen216 enrolled1 locationNCT07359690
Recruiting

The Application of T1 Mapping in Real-World

Hypertrophic Cardiomyopathy (HCM)MyocarditisMyocardial Infarction (MI)+2 more
Chinese Academy of Medical Sciences, Fuwai Hospital2,000 enrolled1 locationNCT07354646
Recruiting

AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy (HCM)Left Ventricular Hypertrophy
Second Affiliated Hospital, School of Medicine, Zhejiang University15,000 enrolled1 locationNCT07263204
Recruiting
Not Applicable

Large Language Models To Improve the Quality of Care of Cardiology Patients

CardiomyopathyCardiologyGenetic Disease+1 more
Stanford University12 enrolled1 locationNCT06935253
Recruiting

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Sudden Cardiac Death+14 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna700 enrolled3 locationsNCT06813443
Recruiting

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

Hypertrophic Cardiomyopathy (HCM)Non-ischemic CardiomyopathyRestrictive Cardiomyopathy+2 more
Scientific Institute San Raffaele15,000 enrolled1 locationNCT06607471